Select for export Psilocybin Therapeutic Research: The Present and Future Paradigm Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.0c00048 PubMed 32292538 Copy citation Copy BibTeX ACS Medicinal Chemistry Letters 2020-03-01 Robert B. Kargbo OpenAlex Published psilocybin DepressionAddictionPharmacology Other More
Select for export Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/chem.202000134 PubMed 32101345 Copy citation Copy BibTeX Chemistry - A European Journal 2020-02-25 Janis Fricke, Robert B. Kargbo, Lars Regestein, Claudius Lenz, Gundela Peschel, Miriam A. Rosenbaum OpenAlex Published psilocybinpsilocin DepressionPharmacologyClinical Trial Clinical Trial More
Select for export Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119895520 PubMed 31941394 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-15 Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionChronic PainBrain Imaging Other More
Select for export Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine) 2019-12-31 Brooke Reichenbach OpenAlex Published psilocybin DepressionAnxietySystematic Review Systematic Review More
Select for export The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Diva portal (Dalarna University Library) 2019-12-31 Sofia Gyllvik OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2019-12-31 Krista Worden OpenAlex Published psilocybin DepressionAnxietyPharmacology Other More
Select for export The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2019.12.023 PubMed 32056741 Copy citation Copy BibTeX Unknown journal 2019-12-13 Mathai DS, Meyer MJ, Storch EA, Kosten TR. Europe PMC Published psilocybin DepressionMechanism of ActionConsciousness Systematic Review More
Select for export Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame No abstract availability was recorded for this entry. Details DOI 10.1016/j.jcbs.2019.11.002 Copy citation Copy BibTeX Journal of Contextual Behavioral Science 2019-11-04 Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Other More
Select for export The psychedelic renaissance: the next trip for psychiatry? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/ipm.2019.39 PubMed 31543078 Copy citation Copy BibTeX Unknown journal 2019-09-22 Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V. Europe PMC Published psilocybin DepressionAnxietyNeuroplasticity Randomized Controlled Trial More
Select for export Psilocybin for depression: Considerations for clinical trial design Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2019.026 Copy citation Copy BibTeX Journal of Psychedelic Studies 2019-08-31 Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Classical psychedelics for the treatment of depression and anxiety: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2019.07.076 PubMed 31382100 Copy citation Copy BibTeX Unknown journal 2019-07-29 Muttoni S, Ardissino M, John C. Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Systematic Review More
Select for export The Potential of Psilocybin Administration in Terminal Cancer Patients Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000574916.46844.cf Copy citation Copy BibTeX Oncology Times 2019-06-27 Richard Simoneaux OpenAlex Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/adt.0000000000000178 Copy citation Copy BibTeX Addictive Disorders & Their Treatment 2019-06-09 Doreen M. Lewis OpenAlex Published psilocybin AnxietyReceptor PharmacologyEmotional Processing Observational Study More
Select for export A Study of Psilocybin for Major Depressive Disorder (MDD) No abstract availability was recorded for this entry. Details DOI 10.31525/ct1-nct03866174 Copy citation Copy BibTeX Case Medical Research 2019-03-06 Kernel Networks Inc. OpenAlex Published psilocybin Depression Other More
Select for export Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2019.01.002 PubMed 30611836 Copy citation Copy BibTeX Unknown journal 2019-01-02 Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z Europe PMC Published psilocybin DepressionSystematic ReviewReview Article Systematic Review More
Select for export Psychedelic drugs in the treatment of anxiety, depression and addiction. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4045/tidsskr.17.1110 PubMed 30421744 Copy citation Copy BibTeX Unknown journal 2018-11-11 Kvam TM, Stewart LH, Andreassen OA. Europe PMC Published psilocybin DepressionAnxietyAddiction Animal Study More
Select for export Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17512433.2018.1511424 PubMed 30102078 Copy citation Copy BibTeX Unknown journal 2018-08-22 Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export DARK Classics in Chemical Neuroscience: Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acschemneuro.8b00186 PubMed 29956917 Copy citation Copy BibTeX Unknown journal 2018-07-15 Geiger HA, Wurst MG, Daniels RN. Europe PMC Published psilocybinpsilocin DepressionAddictionEnd-of-Life Distress Review Article More
Select for export Effects of psilocybin therapy on personality structure. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/acps.12904 PubMed 29923178 Copy citation Copy BibTeX Acta Psychiatrica Scandinavica 2018-06-18 Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ Europe PMC Published psilocybin DepressionMechanism of ActionConsciousness Other More
Select for export Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2018.01.006 PubMed 29407543 Copy citation Copy BibTeX Journal of Affective Disorders 2018-03-31 Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.